Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Cooper

Showing results (111-120 of 268) with videos related to

Pageof 27
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virusMark W Hull, Kathleen Rollet, Adefowope Odueyungbo, et al.
Canadian Liver Journal|August 22, 2022
Real-world health care utilization in treatment of HCV: Results from the Canadian SIMPLE observational trialEdward Tam, Sergio Borgia, Eric M Yoshida, et al.
Journal of Viral Hepatitis|January 9, 2025
Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC AnalysisHimain Perera, Haris Imsirovic, Gisela Macphail, et al.
Contemporary Clinical Trials|February 12, 2008
CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapyMarina B Klein, Curtis Cooper, Marie-Josée Brouillette, et al.
Nature Reviews. Gastroenterology & Hepatology|March 10, 2011
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis CMark S Sulkowski, Curtis Cooper, Bela Hunyady, et al.
Journal of Immigrant and Minority Health|June 7, 2011
HIV knowledge among Canadian-born and sub-Saharan African-born patients living with HIVHeather E Tulloch, Louise Balfour, John Kowal, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
PLOS Digital Health|May 12, 2025
Evaluation of the virtual care experience for persons in prospective cohorts with HIV during the COVID pandemicSharon L Walmsley, Majid Nabipoor, Valerie Martel-Laferriere, et al.
Plos One|April 3, 2018
Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis stagingMakan Golizeh, Carlos E Melendez-Pena, Brian J Ward, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Proceedings of the Canadian Association for HIV Research: Canadian Foundation for Infectious Diseases Professional Development Workshop for Viral ResearchersTrushar R Patel, Keith Fowke, Andrew Matejcic, et al.
Pageof 27

Showing results (111-120 of 268) with videos related to

Sort By:
Pageof 27
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virusMark W Hull, Kathleen Rollet, Adefowope Odueyungbo, et al.
Canadian Liver Journal|August 22, 2022
Real-world health care utilization in treatment of HCV: Results from the Canadian SIMPLE observational trialEdward Tam, Sergio Borgia, Eric M Yoshida, et al.
Journal of Viral Hepatitis|January 9, 2025
Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC AnalysisHimain Perera, Haris Imsirovic, Gisela Macphail, et al.
Contemporary Clinical Trials|February 12, 2008
CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapyMarina B Klein, Curtis Cooper, Marie-Josée Brouillette, et al.
Nature Reviews. Gastroenterology & Hepatology|March 10, 2011
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis CMark S Sulkowski, Curtis Cooper, Bela Hunyady, et al.
Journal of Immigrant and Minority Health|June 7, 2011
HIV knowledge among Canadian-born and sub-Saharan African-born patients living with HIVHeather E Tulloch, Louise Balfour, John Kowal, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
PLOS Digital Health|May 12, 2025
Evaluation of the virtual care experience for persons in prospective cohorts with HIV during the COVID pandemicSharon L Walmsley, Majid Nabipoor, Valerie Martel-Laferriere, et al.
Plos One|April 3, 2018
Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis stagingMakan Golizeh, Carlos E Melendez-Pena, Brian J Ward, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Proceedings of the Canadian Association for HIV Research: Canadian Foundation for Infectious Diseases Professional Development Workshop for Viral ResearchersTrushar R Patel, Keith Fowke, Andrew Matejcic, et al.
Pageof 27